M&A Deal Summary |
|
|---|---|
| Date | 2021-05-20 |
| Target | Bayer s Topical RNA Intellectual Property |
| Sector | Healthcare Services |
| Buyer(s) | GreenLight Biosciences |
| Sellers(s) | Bayer HealthCare AG |
| Deal Type | Divestiture |
SEARCH BY
GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform that can deliver high-quality RNA more quickly and less expensively than previously possible. GreenLight develops RNA products and collaborates with industry leaders to advance human vaccine and therapy development, pandemic preparation, crop management, plant protection and support the health of bees and other pollinators. The GreenLight team values diversity, inclusion, and equality and promises to use collaboration to remain scientifically imaginative and passionately focused on making a difference in the world.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
Bayer HealthCare AG manufactures products to diagnose, prevent, and treat human and animal disease worldwide.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 3 of 3 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-06 |
Domeboro
Cedar Knolls, New Jersey, United States Domeboro is a provider of topical astringent used for relieving itch and minor skin irritations. |
Sell | - |
